In ‘big medicine’ era, innovation essential to sustainability of independent practices
Tumor subclassification provided no additional survival benefit in lung adenocarcinomas
Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS
Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS
William Wood, MD, is an assistant professor of medicine in the division of hematology/oncology at the University of North Carolina in Chapel Hill, as well as a HemOnc Today Editorial Board member.
Although they don’t typically use Google Scholar, patients do use “regular” Google all the time to look for answers to medical questions. Some of the…
Genomic navigators key to proper interpretation of sequencing data
Response-adapted therapy of lymphoma: Real progress or really confusing?
Results demonstrate ‘ongoing need for improvement’ in gastric cancer treatment
This feature offers timely executive summaries of the most relevant journals in hematology and oncology.
This comprehensive Healio resource provides a window into what your colleagues and key opinion leaders are saying about current and future drugs and their impact on patient outcomes.
From the podium to practice. HemOnc Today’s award-winning journalists and editors produce live editorial and video coverage from the most important clinical meetings in hematology and oncology.
Home for important videos from key opinion leaders who provide “Perspective” and insight related current news and information relevant to your medical specialty.
You can find a full listing of all FDA approved drugs for your specialty on Healio.com.
Includes breaking clinical trials and guideline updates from ASCO that could change the current standard of cancer care.
Sheraton New YorkTimes Square Hotel
View past polls
Search Healio's robust listing of national and international medical meetings.
©2014 All Rights Reserved.